The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental ...

After three years of unprecedented tech spending and nonstop hype, the demand for AI in the workplace seems to be drying up fast. Looking at the big picture doesn’t make it any prettier. Back in March ...

With the holidays are just around the corner, your savings might be taking a hit. Why not take a shot at one of the year's biggest Powerball jackpots? Saturday's prize has reached $1 billion and while ...

Were you a lucky winner? Check your tickets for lottery draw games in Nebraska here. 5:59 a.m. ET Jan. 1 *Based on iOS download data collected by Sensor Tower. Jackpocket is the official digital ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...